ABSTRACT
The incidence of coronary heart disease in premenopausal women is lower than in men because of their hormonal protection. Angina pectoris occurs in women about 10 years later than in men. However; mortality from ischaemic heart disease remains higher in women than in men. Current studies are focusing on novel cardiovascular risk biomarkers because it seems that traditional cardiovascular risk factors and their assessment scores underestimate the risk in females. Increased plasma levels of these newly established biomarkers of risk have been found to worsen endothelial dysfunction and inflammation; both of which play a key role in the pathogenesis of microvascular angina; which is very common in women. These novel cardiovascular risk markers can be classified into three categories: inflammatory markers; markers of haemostasis; and other biomarkers